Martin P Däumer

Title: Martin P Däumer: Innovator in Anti-HSV Antibody Research

Introduction

Martin P Däumer is a notable inventor based in Kaiserslautern, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of anti-HSV antibodies. With a total of 2 patents, his work has the potential to impact therapeutic approaches for HSV-associated diseases.

Latest Patents

Däumer's latest patents focus on an anti-HSV antibody. The invention relates to an anti-HSV antibody as defined in the claims, a pharmaceutical composition comprising an effective amount of the said antibody, an expression vector comprising a nucleotide sequence that encodes the said antibody, a host cell comprising the said nucleotide sequence, and a hybridoma cell capable of producing the said antibody. The use of this antibody as a drug, particularly for the manufacture of a drug for the prophylactical or therapeutical treatment of HSV-associated diseases in a subject, is also defined in the claims.

Career Highlights

Throughout his career, Martin P Däumer has worked with prominent organizations such as Heidelberg Immunotherapeutics GmbH and Universität Duisburg Essen. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.

Collaborations

Däumer has collaborated with notable colleagues, including Michael Roggendorf and Anna-Maria Eis-Hübinger. These partnerships have likely enriched his research and fostered innovation in his field.

Conclusion

Martin P Däumer's work in the development of anti-HSV antibodies showcases his commitment to advancing medical science. His patents and collaborations reflect a dedication to improving therapeutic options for patients suffering from HSV-associated diseases.